Literature DB >> 3509291

Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.

C K Svensson1, L L Liu, P W Knowlton.   

Abstract

The effect of amiodarone on hepatic drug metabolism in vivo was examined in the rat using antipyrine as a model substrate. Pretreatment with oral amiodarone hydrochloride, 100 mg/kg/day, for 5 days resulted in a 19% reduction in antipyrine clearance and a 22% increase in half-life. The administration of single oral doses of amiodarone hydrochloride, 100 mg/kg, 1 or 5 hr prior to antipyrine administration had no significant effect on antipyrine pharmacokinetics. The administration of a single intravenous dose of amiodarone hydrochloride, 50 mg/kg, reduced antipyrine clearance by 32% and increased the half-life by 46%. The desethyl metabolite of amiodarone was also found to reduce antipyrine clearance (21%) after a single oral dose of 100 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509291     DOI: 10.1023/a:1016468430618

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

2.  CHRONIC INTRAVENOUS CANNULAS FOR RATS.

Authors:  J R WEEKS; J D DAVIS
Journal:  J Appl Physiol       Date:  1964-05       Impact factor: 3.531

3.  Drug interactions with amiodarone.

Authors:  F I Marcus
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

4.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

5.  Possible interaction between amiodarone and phenytoin.

Authors:  B McGovern; V R Geer; P J LaRaia; H Garan; J N Ruskin
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

6.  Estimation of the turnover rate of barbiturate sidechain oxidation enzyme in rat liver.

Authors:  I M Arias; A De Leon
Journal:  Mol Pharmacol       Date:  1967-03       Impact factor: 4.436

Review 7.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

8.  Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.

Authors:  S Almog; N Shafran; H Halkin; P Weiss; Z Farfel; U Martinowitz; H Bank
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Neurotoxicity in rats following subchronic amiodarone treatment.

Authors:  K S Rao; J C Fernando; I K Ho; H M Mehendale
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1986-05

10.  Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters.

Authors:  D Larrey; M Tinel; P Letteron; J Geneve; V Descatoire; D Pessayre
Journal:  Biochem Pharmacol       Date:  1986-07-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.